Celon Pharma's generic semaglutide drug matches Ozempic in early study, shares jump
- Posted on August 20, 2026
- By Bing News
- 0 Views
- 1 min read
In brief
Generating AI summary…
Celon Pharma's generic semaglutide drug matches Ozempic in early study, shares jump
Aug 20 (Reuters) - Celon Pharma's experimental semaglutide product Reduzek, a generic alternative to Novo Nordisk's Wegovy and Ozempic, matched the blockbuster weight-loss drugs in an early-stage bioequivalence study, the Polish drugmaker said on Thursday. The company's shares surged 14.7% following the publication of selected data from the study, and were on track for their best trading day
